Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Alcohol use linked to NAFLD

Key clinical point: If confirmed prospectively, the results suggest alcohol consumption could be a target for nonalcoholic fatty liver disease control.

Major finding: Each drink per week was associated with a 15% increase in hepatic steatosis risk.

Study details: A retrospective analysis of data from the Framingham Heart Study (n = 2,475).

Disclosures: The study authors received funding from a range of nonindustry sources. They reported having no relevant financial disclosures.

Citation:

Long M et al. Clin Gastroenterol Hepatol. 2019 Nov 14. doi: 10.1016/j.cgh.2019.11.022.